tiprankstipranks
Helus Pharma (HELP)
NASDAQ:HELP
US Market
HELP
Helus Pharma
RESEARCH TOOLSreports
Want to see HELP full AI Analyst Report?

Helus Pharma (HELP) Income Statement

2,476 Followers

Helus Pharma Income Statement

Last quarter (Q3 2026), Helus Pharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Helus Pharma's net income was C$-58.55M. See Helus Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 864.00K
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -311.00K
Operating Expenses
C$ 143.15MC$ 78.84MC$ 51.52MC$ 63.84MC$ 30.72M
Depreciation and Amortization
C$ 475.00KC$ 424.00KC$ 251.00KC$ 168.00KC$ 49.00K
EBITDA
C$ -142.67MC$ -78.41MC$ -51.27MC$ -63.67MC$ -30.99M
Operating Income
C$ -143.15MC$ -78.84MC$ -51.52MC$ -63.84MC$ -31.04M
Other Income/Expenses
C$ 30.01MC$ 756.00KC$ 4.03MC$ -3.79MC$ -1.19M
Pretax Income
C$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63MC$ -32.22M
Net Income
C$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63MC$ -32.22M
Per Share Metrics
Basic EPS
C$ -0.61C$ -3.91C$ -0.22C$ -0.43C$ -12.24
Diluted EPS
C$ -0.61C$ -9.41C$ -0.22C$ -0.43C$ -12.24
Weighted Average Shares Outstanding
 20.22M 20.00M 4.88M 4.40M 2.63M
Weighted Average Shares Outstanding (Diluted)
 20.22M 20.00M 4.88M 4.40M 2.63M
Currency in CAD

Helus Pharma Earnings and Revenue History